Rat folic acid reductase activity during the perinatal period, in newborns, and after trimethoprim administration.
D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn / Q000378:metabolism*; D000890:Anti-Infective Agents / Q000494:pharmacology*; D003609:Dactinomycin / Q000494:pharmacology; D005260:Female; D005333:Fetus / Q000201:enzymology*; D005493:Folic Acid Antagonists / Q000494:pharmacology*; D007668:Kidney / Q000201:enzymology; D008099:Liver / Q000201:enzymology; D008297:Male; D011247:Pregnancy; D011270:Pregnancy, Animal; D011691:Puromycin / Q000494:pharmacology; D011743:Pyrimidines / Q000494:pharmacology*; D051381:Rats; D013053:Spectrophotometry; D013762:Tetrahydrofolate Dehydrogenase / Q000378:metabolism*; D014295:Trimethoprim / Q000008:administration & dosage / Q000494:pharmacology
D000890:Anti-Infective Agents; D005493:Folic Acid Antagonists; D011743:Pyrimidines; D003609:Dactinomycin; D011691:Puromycin; D014295:Trimethoprim; D013762:Tetrahydrofolate Dehydrogenase